https://www.selleckchem.com/pr....oducts/ionomycin.htm
6% vs 25.7%; p less then 0.001), hypercholesterolemia (23.2% vs 41.7%; p less then 0.001) and hypertriglyceridemia (5.8% vs 23.0%; p less then 0.001) increased significantly. Head-to-head comparisons between antipsychotic groups revealed that the ziprasidone group presented significantly smaller increments in weight (p = 0.034) and BMI (p = 0.02 than aripiprazole group. After 3 years of having presented a first episode of psychosis, patients show significant increments in body weight and BMI, as well as in lipid and glycaemic parame